Ascendis Pharma A/S (ASND)

226.37 -4.33 (-1.88%) USD  |  NASDAQ  |  Sep 25, 11:59
More

Ascendis Pharma Cash and Short Term Investments (Quarterly) : 928.66M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 928.66M
March 31, 2026 660.00M
December 31, 2025 723.51M
September 30, 2025 633.43M
June 30, 2025 579.94M
March 31, 2025 559.46M
December 31, 2024 579.41M
September 30, 2024 698.11M
June 30, 2024 277.26M
March 31, 2024 345.86M
December 31, 2023 441.24M
September 30, 2023 482.19M
June 30, 2023 470.33M
March 31, 2023 636.38M
December 31, 2022 784.91M
September 30, 2022 901.09M
June 30, 2022 998.57M
March 31, 2022 1.089B
December 31, 2021 775.64M
September 30, 2021 994.71M
June 30, 2021 653.00M
March 31, 2021 781.23M
December 31, 2020 879.48M
September 30, 2020 1.090B
June 30, 2020 529.64M
Date Value
March 31, 2020 586.35M
December 31, 2019 671.37M
September 30, 2019 718.07M
June 30, 2019 786.18M
March 31, 2019 782.25M
December 31, 2018 317.64M
September 30, 2018 360.45M
June 30, 2018 411.68M
March 31, 2018 428.49M
December 31, 2017 234.58M
September 30, 2017 243.88M
June 30, 2017 145.21M
March 31, 2017 168.61M
December 31, 2016 190.20M
September 30, 2016 83.75M
June 30, 2016 100.82M
March 31, 2016 116.08M
December 31, 2015 129.97M
September 30, 2015 143.16M
June 30, 2015 153.60M
March 31, 2015
December 31, 2014 60.70M
September 30, 2014 9.991M
June 30, 2014 16.10M
March 31, 2014

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 874.00M
Novo Nordisk A/S 6.880B
Evaxion AS 14.00M
Genmab A/S 1.503B
Zealand Pharma A/S 2.211B